FDA Approves First Direct-to-Consumer Test for Breast Cancer Risk

By |2018-03-08T11:20:52+00:00March 8th, 2018|News|

Federal regulators approved the first direct-to-consumer test for the BRCA genes, which increase the risk of breast and ovarian cancer, the agency announced on Tuesday. To the article (Scientific American)